Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for prevention of Crohn's disease recurrence
NCT02417974Phase 2Terminated
- Sponsor
- Boston Medical Center
- Start
- Sep 2015
- Primary completion
- Feb 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of fecal microbiome transplant in Crohn's disease, sponsored by Boston Medical Center. Started Sep 2015; status: terminated.
02
Drugs
fecal microbiome transplant
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02417974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417974.